Skeletal muscle Ca_V1.1 channelopathies

Area of Science:

• Molecular biology
• Muscle physiology
• Genetics

Background:

• Calcium voltage-gated channel subfamily 1 member 1 (Ca_V1.1) is primarily expressed in skeletal muscle.
• Ca_V1.1 acts as a voltage sensor in skeletal muscle excitation-contraction (EC) coupling, separate from its L-type calcium channel activity.
• All known Ca_V1.1-related diseases manifest as muscle disorders due to its dual functions in skeletal muscle.

Purpose of the Study:

• To review the general roles of Ca_V1.1 in disease.
• To discuss the current understanding of the pathophysiology of Ca_V1.1-related skeletal muscle diseases.
• To emphasize the molecular mechanisms underlying these muscle diseases.

Main Methods:

• Literature review and synthesis of existing research on Ca_V1.1.
• Analysis of genetic mutations and splicing defects associated with Ca_V1.1.
• Discussion of molecular and cellular mechanisms in affected muscle tissues.

Main Results:

• Four types of muscle diseases are linked to Ca_V1.1 gene mutations or splicing defects: hypokalemic/normokalemic periodic paralysis, malignant hyperthermia susceptibility, Ca_V1.1-related myopathies, and myotonic dystrophy type 1.
• Native American myopathy involves impaired Ca_V1.1 function due to mutations in the associated protein STAC3.
• The study highlights the critical role of Ca_V1.1 in skeletal muscle EC coupling and its implications in disease.

Conclusions:

• Ca_V1.1's specific role in skeletal muscle EC coupling underpins its involvement in various muscle diseases.
• Understanding the molecular mechanisms of Ca_V1.1 dysfunction is key to addressing these debilitating muscle conditions.
• Further research into Ca_V1.1 and associated proteins is essential for developing targeted therapies for muscle diseases.